Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
about
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.The potential and hurdles of targeted alpha therapy - clinical trials and beyond.Novel radiolabeled antibody conjugates.Cancer radioimmunotherapy.Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.Review of clinical radioimmunotherapy.Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma.The status of radioimmunotherapy in CD20+ non-Hodgkin's lymphoma.Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts.Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy.Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer.Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal.Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.A mechanistic compartmental model for total antibody uptake in tumors.Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.Synthesis and biodistribution studies of iodine-131 D-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody
P2860
Q33645793-7DDDF0A7-D4DD-4BE1-A23F-1D98EF60DBC2Q34298754-E0C424C9-09F1-4C18-B70D-4CA8BC43FEC8Q34399879-F2C2E05A-31B6-45F7-ACA5-12523902698BQ34631801-38B06D45-FC17-4282-AEF6-8253F048CB11Q35070045-108B43E6-8783-4418-87BC-7A9F8A212E4FQ35851824-DA1AA7E4-E4A6-4D2B-804E-70F493325828Q36021361-3357AFE9-4EEE-4CFE-82D7-6C92CDC8D7CDQ36082355-A20059E5-01D1-4F4C-81BF-4D933B60014FQ36407480-EE3AABAC-9F31-4CED-AE81-7465790EA16BQ36684500-88B27DD5-FDB3-489A-85E2-6AA198839DDAQ38215613-0F8F9DBA-2F0B-4CA6-BEEF-768E4B83B65EQ38696425-CC4614E6-9B10-4CC5-9DAC-E4A8601ED59BQ38765188-8CB85543-74E8-4CF7-8715-D83AB1CF7362Q38808823-D2427931-4C91-4FBD-89F5-F716FEE69207Q40426685-D8DA59FE-C367-46E4-AD40-84C2FEF5F90BQ42038270-5D01E689-A230-4A78-8BB4-9F1D6F687B86Q43066289-B250793C-9CD3-4AF0-BE93-994F05B0DBCDQ45957722-320F087E-7B5D-4318-AB65-45CE7CDC9EC8Q57815952-EE524C4A-917D-481A-8729-5FD81A55215A
P2860
Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@ast
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@en
type
label
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@ast
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@en
prefLabel
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@ast
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@en
P1476
Radiobiology of radioimmunothe ...... gen in non-Hodgkin's lymphoma.
@en
P2093
M Carmen Hernandez
Susan J Knox
P304
P356
10.1016/J.IJROBP.2004.02.065
P407
P577
2004-08-01T00:00:00Z